Swiss Tropical and Public Health Institute, Basel, Switzerland.
University of Basel, Basel, Switzerland.
PLoS Negl Trop Dis. 2022 May 27;16(5):e0010463. doi: 10.1371/journal.pntd.0010463. eCollection 2022 May.
Schistosomiasis, an acute and chronic parasitic disease caused by human pathogenic Schistosoma species, is a neglected tropical disease affecting more than 220 million people worldwide. For diagnosis of schistosomiasis, stool and urine microscopy for egg detection is still the recommended method, however sensitivity of these methods is limited. Therefore, other methods like molecular detection of DNA in stool, detection of circulating cathodic antigen in urine or circulating anodic antigen in urine and serum, as well as serological tests have gained more attention. This study examines the sensitivity and specificity of a rapid diagnostic test based on immunochromatography (Schistosoma ICT IgG-IgM, LD Bio, Lyon, France) for simultaneous detection of specific IgG and IgM antibodies in serum, against Schistosoma spp. in endemic and non-endemic populations.
METHODOLOGY/PRINCIPAL FINDINGS: Frozen banked serum samples from patients with confirmed schistosomiasis, patients with other helminth infections, patients with seropositive rheumatoid arthritis and healthy blood donors were used to assess the sensitivity and the specificity of the Schistosoma ICT IgG-IgM rapid diagnostic test. The test showed a sensitivity of 100% in patients with parasitologically confirmed schistosomiasis, irrespective of the species (S. mansoni, S. haematobium, S. japonicum, S. mekongi). In healthy blood donors and patients with rheumatoid factor positive rheumatoid arthritis from Europe, specificity was 100%. However, in serum samples of patients with other tissue invasive helminth infections, the test showed some cross-reactivity, resulting in a specificity of 85%.
CONCLUSION/SIGNIFICANCE: With its high sensitivity, the Schistosoma ICT IgG-IgM rapid diagnostic test is a suitable screening test for detection of Schistosoma specific antibodies, including S. mekongi. However, in populations with a high prevalence of co-infection with other tissue invasive helminths, positive results should be confirmed with other diagnostic assays due to the test's imperfect specificity.
血吸虫病是一种由人类致病性血吸虫引起的急性和慢性寄生虫病,是一种被忽视的热带病,影响着全球超过 2.2 亿人。对于血吸虫病的诊断,粪便和尿液显微镜检查卵检测仍然是推荐的方法,然而这些方法的敏感性有限。因此,其他方法,如粪便中 DNA 的分子检测、尿液中循环阴极抗原或尿液和血清中的循环阳极抗原以及血清学检测,已经引起了更多的关注。本研究检查了一种基于免疫层析法(Schistosoma ICT IgG-IgM,LD Bio,里昂,法国)的快速诊断测试的敏感性和特异性,用于同时检测血清中针对血吸虫属 spp.的特异性 IgG 和 IgM 抗体,在流行区和非流行区人群中。
方法/主要发现:使用冷冻保存的血清样本来自确诊的血吸虫病患者、其他寄生虫感染患者、血清阳性类风湿关节炎患者和健康献血者,以评估 Schistosoma ICT IgG-IgM 快速诊断测试的敏感性和特异性。该测试在寄生虫学证实的血吸虫病患者中显示出 100%的敏感性,与物种无关(曼氏血吸虫、埃及血吸虫、日本血吸虫、湄公血吸虫)。在欧洲的健康献血者和类风湿因子阳性类风湿关节炎患者中,特异性为 100%。然而,在其他组织侵袭性寄生虫感染患者的血清样本中,该测试显示出一些交叉反应,导致特异性为 85%。
结论/意义:Schistosoma ICT IgG-IgM 快速诊断测试具有高灵敏度,是检测血吸虫特异性抗体的合适筛选测试,包括湄公血吸虫。然而,在其他组织侵袭性寄生虫感染流行率较高的人群中,由于测试的特异性不完善,阳性结果应通过其他诊断检测来确认。